METHOD FOR PREDICTION OF DEVELOPMENT OF TYPE TWO DIABETES MELLITUS IN PATIENTS WITH METABOLIC SYNDROME Russian patent published in 2016 - IPC G01N33/48 

FIELD: medicine.

SUBSTANCE: invention relates to cardiology and endocrinology, and concerns prediction of developing type two diabetes mellitus in patients with metabolic syndrome. That is ensured by determining content of aspartate aminotransferase (x₁), end systolic volume of left ventricle (x₂), final diastolic left ventricular volume (x₃), content of alanine aminotransferase (x₄), systolic blood pressure (x₅), size of left atrium (x₆), content of triglycerides (x₇), cortisol (x₈), sugar in blood serum two hours after meals (x₉), patient's age (x), patient's body weight index (x₁₁), presence or absence of patient's history and diabetes of second type (x₁₂) to calculate stratification risk index (G)(x)=0.27·x₁+0.28·x₂+5.03·x₃+0.25·x₄+0.12·x₅+1.93·x₆-3.13·x₇+0.28·x₈+1.05·x₉+0.17·x₁₀+0.06·x₁₁+0.59·x₁₂. If G(x) exceeds 88.1, risk of diabetes is considered to be high, otherwise as insignificant.

EFFECT: method provides patient-specific prediction of risk of diabetes mellitus taking into account individual data of each specific patient metabolic syndrome.

1 cl, 2 ex